It has been demonstrated that CLDN1 downregulation in pancreatic cancer results in the phosphorylation of FAK and paxillin, which further promotes cell invasion, migration, and tumor metastasis (23). The gene discussed is CLDN1; the disease is pancreatic neoplasm.